All Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial Articles
-
250Products & ServicesVTI’s Dr. Ashley Tuan Shares PROTECT Study’s One-Year Results
sponsored content March 4, 2024 In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the...
-
433Latest Myopia NewsVTI Shares Ongoing Results of One-Year PROTECT Trial
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
-
466ClinicalPROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control
sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...
-
468Products & ServicesJuan Carlos Aragón Discusses His New CEO Role at Visioneering Technologies
sponsored content October 12, 2023 At the American Academy of Optometry’s Annual Meeting, Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Dr. Juan...
-
466Latest Myopia NewsVTI Shares One-Year Data from PROTECT Trial at AAO 2023
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
-
1.1KClinicalVTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...